White Paper
India as a Promising Location for Immuno-Oncology Trials
India, with its many advantages, remains on track to become a major center for clinical trials and should be routinely considered by international sponsors for global IO trials.
Oct 12, 2020

Use of IO therapies – including immune checkpoint inhibitors – in clinical care and clinical trials for solid tumors was the topic of an advisory board meeting held in Mumbai, India on February 8, 2020, by the IQVIA medical and clinical team with Key Opinion Leaders from various regions of India. The White Paper covers the salient topics discussed.

Contact Us